| Dr Matthew Allen Butler, MD | |
|
9119 W 74th St Ste 350, Merriam, KS 66204-2268 | |
| (913) 632-9400 | |
| (913) 632-9444 |
| Full Name | Dr Matthew Allen Butler |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 14 Years |
| Location | 9119 W 74th St Ste 350, Merriam, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326359308 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 04-36315 (Kansas) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 04-36315 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| Adventhealth Ottawa | Ottawa, KS | Hospital |
| Kansas City Orthopaedic Institute | Leawood, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawnee Mission Medical Center Inc | 9537119037 | 177 |
News Archive
A Simon Fraser University researcher is going to Vietnam to study how to address the shortage of accessible and adequate services for people with mental disorders like depression and anxiety.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
"Nations have crafted a draft treaty to fight a booming trade in illicit tobacco products that's costing governments as much as $50 billion a year in lost tax revenue, officials said Wednesday," the Associated Press/Washington Post reports.
Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.
SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.
› Verified 4 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735690 PECOS PAC ID: 9537119037 Enrollment ID: O20050701000310 |
News Archive
A Simon Fraser University researcher is going to Vietnam to study how to address the shortage of accessible and adequate services for people with mental disorders like depression and anxiety.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
"Nations have crafted a draft treaty to fight a booming trade in illicit tobacco products that's costing governments as much as $50 billion a year in lost tax revenue, officials said Wednesday," the Associated Press/Washington Post reports.
Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.
SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.
› Verified 4 days ago
| Entity Name | Adventhealth Ransom Memorial Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407319957 PECOS PAC ID: 4486996907 Enrollment ID: O20190510001418 |
News Archive
A Simon Fraser University researcher is going to Vietnam to study how to address the shortage of accessible and adequate services for people with mental disorders like depression and anxiety.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
"Nations have crafted a draft treaty to fight a booming trade in illicit tobacco products that's costing governments as much as $50 billion a year in lost tax revenue, officials said Wednesday," the Associated Press/Washington Post reports.
Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.
SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Allen Butler, MD 9119 W 74th St Ste 350, Merriam, KS 66204-2268 Ph: (913) 632-9400 | Dr Matthew Allen Butler, MD 9119 W 74th St Ste 350, Merriam, KS 66204-2268 Ph: (913) 632-9400 |
News Archive
A Simon Fraser University researcher is going to Vietnam to study how to address the shortage of accessible and adequate services for people with mental disorders like depression and anxiety.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
"Nations have crafted a draft treaty to fight a booming trade in illicit tobacco products that's costing governments as much as $50 billion a year in lost tax revenue, officials said Wednesday," the Associated Press/Washington Post reports.
Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.
SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.
› Verified 4 days ago
Mazda Biria, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St Ste 350, Merriam, KS 66204 Phone: 913-632-9400 Fax: 913-632-9444 | |
Dr. David R Kennedy, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7450 Kessler St, Ste 300, Merriam, KS 66204 Phone: 913-632-2900 Fax: 913-632-2999 | |
Dr. Thaju Salam, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St Ste 350, Merriam, KS 66204 Phone: 913-632-9400 Fax: 913-632-9444 | |
Alexander Eric Fong, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7450 Kessler St Ste 205, Merriam, KS 66204 Phone: 913-632-9810 Fax: 913-632-9828 | |
Dr. John M Singleton Iii, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 9908 Edelweiss Cir, Merriam, KS 66203 Phone: 913-403-0296 | |
John Paul Lecluyse, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9100 W 74th St, Merriam, KS 66204 Phone: 913-632-9400 |